[{"OtherAssetsCurrent_0_Q1_USD":277000.0,"AdditionalPaidInCapital_0_Q1_USD":194544000.0,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":100000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":25600000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":2519000.0,"InterestAndOtherIncome_1_Q1_USD":72000.0,"Liabilities_0_Q1_USD":1145000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":25977000.0,"LiabilitiesCurrent_0_Q1_USD":1145000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_1_Q1_USD":100000.0,"ProceedsFromWarrantExercises_1_Q1_USD":3613000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":778000.0,"LesseeOperatingLeaseDiscountRate_0_Q1_pure":0.055,"PropertyPlantAndEquipmentNet_0_Q1_USD":33000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":24481000.0,"StockholdersEquity_0_Q1_USD":24832000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":24832000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.05,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-169737000.0,"OperatingExpenses_1_Q1_USD":1222000.0,"OperatingIncomeLoss_1_Q1_USD":-1222000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":67000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":67000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q1_USD":67000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q1_USD":75000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":270000.0,"NetIncomeLoss_1_Q1_USD":-1150000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-1194000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":100000.0,"CertificatesOfDepositAtCarryingValue_0_Q1_USD":20000000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":14000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":72000.0,"AccountsPayableCurrent_0_Q1_USD":608000.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":9000.0,"IncreaseDecreaseInOtherCurrentLiabilities_1_Q1_USD":2000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":14000.0,"Assets_0_Q1_USD":25977000.0,"AssetsCurrent_0_Q1_USD":25877000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"CommitmentsAndContingencies_0_Q1_USD":null,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockValue_0_Q1_USD":null,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommonStockSharesAuthorized_0_Q1_shares":120000000.0,"CommonStockSharesIssued_0_Q1_shares":24729902.0,"CommonStockSharesOutstanding_0_Q1_shares":24729902.0,"CommonStockValue_0_Q1_USD":25000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":387000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":155000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-390000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":3613000.0,"ShareBasedCompensation_1_Q1_USD":270000.0,"OtherLiabilitiesCurrent_0_Q1_USD":11000.0,"Ticker":"SAVA","CIK":"1069530","name":"CASSAVA SCIENCES INC","OfficialName":"Cassava Sciences Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"898902969.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200506"}]